HK Stock Market Move | EC HEALTHCARE (02138) continued to fall by more than 7%, with the overall sales expected to decrease by up to 4% year-on-year in the mid-term.
12/11/2024
GMT Eight
EC HEALTHCARE (02138) continues to fall by over 7%, at the time of publication, down 7.04% to 0.66 Hong Kong dollars with a trading volume of 704,100 Hong Kong dollars.
In terms of news, EC HEALTHCARE announced that for the six months ending on September 30, 2024, it expects the overall sales to be not less than 2.1 billion Hong Kong dollars, a year-on-year decrease of not more than 4%; the sales of medical services provided by the group are expected to decline by not more than 3% year-on-year; the sales of aesthetic medical, beauty, and wellness services in Hong Kong and Macau by the group are expected to decline by not more than 5% year-on-year; the sales of aesthetic medical, beauty, and wellness services in mainland China by the group are expected to decline by not more than 49% year-on-year; and the sales of other services by the group are expected to increase by not less than 12% year-on-year.
EC HEALTHCARE also announced the sale of 51% of the equity of New Medical Centre, a subsidiary providing medical services and medical imaging services, to an independent third party for 438 million Hong Kong dollars. At the same time, they will acquire the remaining 40% of the equity of HKMAI TST, a subsidiary providing advanced medical imaging services, to make it a wholly-owned subsidiary, for 16.94 million Hong Kong dollars, with the intention to allocate internal resources for the transaction.